Since the expression of ECT2 in different subgroups with distinct histological or molecular traits is all elevated, we hypothesized that ECT2 might play a conserved role in survival promotion of all subtypes of breast carcinoma even though its GEF activity is absent or insufficient. The gene discussed is ARHGEF2; the disease is breast carcinoma.